PAREXEL develops cold-chain data system

Global contract researcher PAREXEL has stepped into the cold chain business. The company has unveiled an integrated study-drug transport system for temperature monitoring based on radio-frequency identification technology.

The system is part of the company's clinical logistics service offering and PAREXEL says it shaves a day off the time required for investigators to begin using experimental drugs in clinical trials.

Traditional methods involve the shipment of temperature-monitoring devices and their return to a hub for analysis before study drugs can be OK'd for use. The CRO's system, however, incorporates an RFID/sensor chip for en route temperature recording and a mobile phone in the drug packaging for the collection and transmission of temperature data. The system checks temperature at pre-set times during shipment. At the clinic, staffers access the RFID data and transmit it to a hub for review. If the temperature stays in range during transport, clinicians are given the green light to release the drug for use in the trial.

- see the Parexel announcement

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.